Drug Interaction Study of the Effect on Cyclosporine on Ozanimod and Major Active Metabolites

    Not Recruiting
  • participants needed
  • sponsor
Updated on 20 January 2022
body mass index
tubal ligation
hormonal contraception
social interactions
12 lead ECG
drug interaction


This is a Phase 1, randomized, parallel-group, open-label study. Forty subjects will be enrolled and will be randomized into 1 of the 2 treatment groups, with 20 subjects in each treatment group(sex will be used as a stratifying factor) as follows:

  • Treatment Group A (reference): A single oral dose of ozanimod 0.46 mg
  • Treatment Group B (test): A single oral dose of ozanimod 0.46 mg plus a single oral dose of cyclosporine 600 mg

Condition Healthy Volunteers
Treatment cyclosporine, Ozanimod
Clinical Study IdentifierNCT04149678
Last Modified on20 January 2022

Similar trials to consider


Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 



Reply by • Private

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note